Bron L, Brossard E, Monnier P, Pasche P
Department of ENT and Head and Neck Surgery, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Laryngoscope. 2000 Apr;110(4):627-34. doi: 10.1097/00005537-200004000-00017.
To review the patients operated in our department with supracricoid partial laryngectomy with either cricohyoidoepiglottopexy (CHEP) (59 cases) or cricohyoidopexy (CHP) (10 cases) technique, for primary or recurrent glottosupraglottic squamous cell carcinoma and compare the technique with other surgical or conservative approaches for treatment of laryngeal carcinoma.
From hospital charts, we retrospectively reviewed 69 patients who had undergone supracricoid partial laryngectomy with the CHEP or CHP technique between 1983 and 1996 for primary or recurrent glottosupraglottic squamous cell carcinoma in our department. Statistical evaluation of oncological and functional results were conducted. Results were compared with other surgical and conservative treatment for glottosupraglottic carcinoma of the larynx that were published previously in the literature.
Sixty-nine patients had CHEP or CHP for glottosupraglottic carcinoma of the larynx. Thirteen percent of the patients received adjuvant radiotherapy. Minimum follow-up was 2 years or until death. Five-year actuarial survival (Kaplan-Meier method) was 68%. Global local control was achieved in 84% of cases. Among previously untreated patients (n = 54), local control rate was 94.5%. After 1 year, 92.7% of patients achieved normal swallowing and respiration. Salvage total laryngectomy had to be performed in four patients (5.7%) for persistent aspiration and in five patients (7.2%), who were previously treated with radiotherapy, for local recurrence. No permanent tracheostomy or gastrostomy was required.
Our experience with supracricoid partial laryngectomy with either CHP or CHEP suggests that this technique is a valuable alternative to radiotherapy for T2-T4 glottosupraglottic carcinomas, particularly those with extension and invasion of the anterior commissure. It allows for preservation of a good laryngeal function without altering the long-term survival, keeping total laryngectomy as a salvage procedure.
回顾在我科接受环甲膜会厌固定术(CHEP)(59例)或环甲膜固定术(CHP)(10例)的原发性或复发性声门上型鳞状细胞癌患者,并将该技术与其他治疗喉癌的手术或保守方法进行比较。
从医院病历中,我们回顾性分析了1983年至1996年间在我科接受CHEP或CHP技术的69例原发性或复发性声门上型鳞状细胞癌患者。对肿瘤学和功能结果进行了统计学评估。将结果与先前文献中发表的其他声门上型喉癌手术和保守治疗方法进行比较。
69例患者接受了CHEP或CHP治疗声门上型喉癌。13%的患者接受了辅助放疗。最短随访时间为2年或直至死亡。5年精算生存率(Kaplan-Meier法)为68%。84%的病例实现了总体局部控制。在未经治疗的患者(n = 54)中,局部控制率为94.5%。1年后,92.7%的患者吞咽和呼吸恢复正常。4例患者(5.7%)因持续性误吸而不得不进行挽救性全喉切除术,5例先前接受过放疗的患者(7.2%)因局部复发而进行了挽救性全喉切除术。无需永久性气管造口术或胃造口术。
我们使用CHP或CHEP进行环状软骨上部分喉切除术的经验表明,对于T2-T4声门上型癌,特别是那些侵犯前联合的癌,该技术是放疗的一种有价值的替代方法。它能够在不改变长期生存率的情况下保留良好的喉功能,将全喉切除术作为挽救性手术。